Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Domvanalimab plus zimberelimab in unresectable and immunotherapy refractory biliary tract cancers: a phase 2 trial.
Journal: Nature communications
Published: December 16, 2025
A Unique Case of Concomitant T-Prolymphocytic Leukemia and B-Cell Acute Lymphoblastic Leukemia.
Journal: EJHaem
Published: August 05, 2025
Retrospective Analysis of HAIP Therapy in Metastatic Colorectal Cancer: Efficacy, Safety, and Prognostic Factors.
Journal: Journal of gastrointestinal cancer
Published: July 30, 2025
Patient Characteristics and Outcomes of Nodular Lymphocyte-Predominant Hodgkin's Lymphoma at a Safety-Net System Compared to an Academic Comprehensive Cancer Center.
Journal: Acta haematologica
Published: March 17, 2025
Dual TIGIT and PD-1 blockade with domvanalimab plus zimberelimab in hepatocellular carcinoma refractory to anti-PD-1 therapies: the phase 2 LIVERTI trial.
Journal: Nature communications
Published: January 03, 2025
Implementing a Novel "Frontiers in Neoplasia" Curriculum to Engage Fourth-Year Medical Students in Evidence-Based, Multidisciplinary Oncology Care.
Journal: Journal of cancer education : the official journal of the American Association for Cancer Education
Published: December 18, 2024
Racial Differences in Systemic Immune Parameters in Individuals With Lung Cancer.
Journal: JTO clinical and research reports
Published: June 26, 2024
Differences in systemic immune parameters in individuals with lung cancer according to race.
Journal: bioRxiv : the preprint server for biology
Published: June 25, 2024
Racial and ethnic disparities in Acute Myeloid Leukemia: 15-year experience at a safety net hospital system.
Journal: Leukemia research
Published: November 28, 2023
Sustained long-term remission with tyrosine kinase inhibitor therapy in treatment-refractory B-cell acute lymphoblastic leukemia harboring a RCSD1::ABL2 fusion gene.
Journal: Leukemia & lymphoma
Published: October 09, 2023
The phosphatidylserine targeting antibody bavituximab plus pembrolizumab in unresectable hepatocellular carcinoma: a phase 2 trial.
Journal: Nature communications
Published: September 20, 2023
Outcomes in Kaposi's sarcoma-associated herpesvirus -associated primary effusion lymphoma and multicentric Castleman's disease in patients with human immunodeficiency virus (HIV) in a safety-net hospital system.
Journal: European journal of haematology
Published: September 12, 2023
Last Updated: 09/26/2026